JAK/STAT Signaling in Hematopoietic Stem Cells
JAK/STAT Signaling in Hematopoietic Stem Cells
批准号:
6707007
负责人:
Kevin D Bunting
金额:
$0.77万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-03-01 至 2004-06-30
关键词:
JAK kinaseapoptosisbiological signal transductionbone marrowcell cyclecell differentiationcell growth regulationcell proliferationcell surface receptorscytokineenzyme activityflow cytometryfluorescent dye /probegene expressiongene induction /repressionhematopoiesishematopoietic stem cellshematopoietic tissue transplantationlaboratory mousepolymerase chain reactionprotein structure functionstem cell transplantationterminal nick end labelingtissue /cell culturetranscription factor
中文摘要
描述(申请人提供):这项工作的长期目标是
识别和表征可能在两种正常情况下都发挥重要作用的基因
和恶性血液病。具体地说,我们有兴趣定义
造血干细胞自我更新与分化的调控
细胞命运的决定。造血干细胞对骨髓(BM)有潜在用途
基因疾病和癌症的移植,作为基因治疗的目标,
并作为体外生成血细胞产品的前体。体外实验
保持原始属性和功能活动的HSC的扩展
仍然是一个重要的研究目标,考虑到
HSCs的潜在应用。生长因子信号转导
已知的途径是通过以下途径影响特定谱系的HSC分化
作为生存因子防止细胞凋亡,并通过传递一种
增殖信号。HSCs与BM相互作用的附加调制
间质微环境可由生长因子刺激引起。我们的目标
该项目的目的是确定JAKISTAT信号的要求
肝星状细胞对特定生长因子反应的转导途径
可以激活STATS并在短期体外保持HSC活性
文化。在造血干细胞中可以利用多种信号转导途径
在配体与细胞表面受体结合后,因此这些
路径可能是多余的。因此,统计信息在原语中的作用
从生物化学分析不能预测造血水平
分化的细胞。我们的初步研究表明,来自
缺乏Stat5a和STAT5b表达的小鼠表现出明显的
在不减少绝对值的情况下进行竞争性的长期再填充活动
干细胞数量。然而,需要确定缺陷是否为
与细胞周期诱导、细胞凋亡或归巢/植入改变有关
才能。我们建议利用分子遗传学方法,如
逆转录病毒介导的小鼠基因转移和纯合子基因破坏
表征和区分STAT3和STAT5在
造血干细胞功能。将实现以下具体目标
在这项研究中。1)我们将确定STAT5在生长因子中的作用
活跃在造血干细胞中的信号通路。2)我们会
确定STAT3在活跃的生长因子信号通路中的作用
在造血干细胞中。总之,这项工作将提供对
造血干细胞的基本生物学,并可能最终导致新的方法
可移植干细胞的体外扩增用于治疗
可用于临床。
英文摘要
DESCRIPTION (provided by applicant): The long-term objectives of this work are
to identify and characterize genes that may play important roles in both normal
and malignant hematopoiesis. Specifically, we are interested in defining
regulators of hematopoietic stem cell (HSC) self-renewal versus differentiation
cell fate decisions. HSCs are potentially useful for bone marrow (BM)
transplantation for genetic disease and cancer, as targets for gene therapy,
and as precursors for generation of blood cell products in vitro. Ex vivo
expansion of HSCs that maintain primitive properties and functional activity
continues to be an important research objective, considering the number of
potential applications for use of HSCs. Growth factor signal transduction
pathways are known to affect HSC differentiation along specific lineages by
acting as survival factors to prevent apoptosis and by imparting a
proliferative signal. Additional modulation of interactions of HSCs with the BM
stromal microenvironment can be caused by growth factor stimulation. Our goal
for this project is to determine the requirement for the JAKISTAT signal
transduction pathway in the response of HSCs to specific growth factors that
can activate STATs and also maintain HSC activity during short-term ex vivo
culture. Multiple signal transduction pathways could be utilized in HSCs
following ligand binding to the cell surface receptor and therefore these
pathways could be redundant. For this reason, the role of STATs in primitive
levels of hematopoiesis cannot be predicted from biochemical analysis of
differentiated cells. Our initial studies have revealed that stem cells from
mice lacking STAT5a and STAT5b expression show a marked deficiency in
competitive long-term repopulating activity without a reduction in the absolute
stem cell number. However, it needs to be determined whether the defect is
related to cell cycle induction, apoptosis, or alteration in homing/engraftment
ability. We propose to utilize molecular genetic approaches such as
retroviral-mediated gene transfer and homozygous gene disruption in mice to
characterize and distinguish the functional roles of STAT3 and STAT5 in
hematopoietic stem cell function. The following specific aims will be addressed
in this study. 1) We will determine the role of STAT5 in growth factor
signaling pathways that are active in hematopoietic stem cells. 2) We will
determine the role of STAT3 in growth factor signaling pathways that are active
in hematopoietic stem cells. Altogether, this work will provide insight into
the basic biology of HSCs and perhaps ultimately lead to novel methods for
expansion of transplantable stem cells in vitro for therapeutic approaches that
could be used clinically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of protein methylation to improve hematopoietic stem cell engraftment
-
批准号:10370387
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2020
-
负责人:Kevin D Bunting
-
依托单位:
STAT5 Structure-Function in Hematopoiesis
-
批准号:7891083
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:Kevin D Bunting
-
依托单位:
NHLBI Research Opportunities for Minority Students
-
批准号:7425797
-
项目类别:
-
资助金额:$9.24万
-
财政年份:2005
-
负责人:Kevin D Bunting
-
依托单位:
Role of TIMPs in Hematopoietic Stem Cell Biology
-
批准号:6766886
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2003
-
负责人:Kevin D Bunting
-
依托单位:
Role of TIMPs in Hematopoietic Stem Cell Biology
-
批准号:7090866
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2003
-
负责人:Kevin D Bunting
-
依托单位:
Role of TIMPs in Hematopoietic Stem Cell Biology
-
批准号:6663597
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2003
-
负责人:Kevin D Bunting
-
依托单位:
Role of TIMPs in Hematopoietic Stem Cell Biology
-
批准号:6921335
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2003
-
负责人:Kevin D Bunting
-
依托单位:
JAK/STAT Signaling in Hematopoietic Stem Cells
-
批准号:6829142
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
STAT5 Structure-Function in Hematopoiesis
-
批准号:8133428
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
JAK/STAT Signaling in Hematopoietic Stem Cells
-
批准号:7002741
-
项目类别:
-
资助金额:$24.5万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
JAK/STAT Signaling in Hematopoietic Stem Cells
-
批准号:6908325
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
Mechanisms of STAT5 function in hematopoietic stem and progenitor cells
-
批准号:8502966
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
STAT5 Structure-Function in Hematopoiesis
-
批准号:7883524
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
Mechanisms of STAT5 function in hematopoietic stem and progenitor cells
-
批准号:9256459
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
JAK/STAT Signaling in Hematopoietic Stem Cells
-
批准号:6433897
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
JAK/STAT Signaling in Hematopoietic Stem Cells
-
批准号:6621328
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
Signaling Mechanisms in Stem Cell Plasticity
-
批准号:6896330
-
项目类别:
-
资助金额:$11.18万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
Signaling Mechanisms in Stem Cell Plasticity
-
批准号:6637384
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
STAT5 Structure-Function in Hematopoiesis
-
批准号:7363253
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
STAT5 Structure-Function in Hematopoiesis
-
批准号:7587511
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2002
-
负责人:Kevin D Bunting
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: